mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.5 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.0079 |
0.8 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.3 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.5 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.0041 |
0.9 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
-0.037 |
0.2 |